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Abstract
Direct interaction with the b subunit of the heterotrimeric G protein complex causes voltage-dependent inhibition
of N-type calcium channels. To further characterize the molecular determinants of this interaction, we performed
scanning mutagenesis of residues 372-387 and 410-428 of the N-type channel a1 subunit, in which individual resi-
dues were replaced by either alanine or cysteine. We coexpressed wild type Gb1g2 subunits with either wild type
or point mutant N-type calcium channels, and voltage-dependent, G protein-mediated inhibition of the channels
(VDI) was assessed using patch clamp recordings. The resulting data indicate that Arg376 and Val416 of the a1 subu-
nit, residues which are surface-exposed in the presence of the calcium channel b subunit, contribute significantly
to the functional inhibition by Gb1. To further characterize the roles of Arg
376 and Val416 in this interaction, we per-
formed secondary mutagenesis of these residues, coexpressing the resulting mutants with wild type Gb1g2 subu-
nits and with several isoforms of the auxiliary b subunit of the N-type channel, again assessing VDI using patch
clamp recordings. The results confirm the importance of Arg376 for G protein-mediated inhibition and show that a
single amino acid substitution to phenylalanine drastically alters the abilities of auxiliary calcium channel subunits
to regulate G protein inhibition of the channel.
Background
The mammalian nervous system expresses nine different
genes that encode different types of voltage-gated cal-
cium channel (VGCC) a1 subunits which interact with
auxiliary subunits and form classes of VGCCs that are
distinct in structure, pharmacology, and physiology [1].
VGCCs containing the a1A and a1B subunits (P/Q- and
N-type channels respectively) are distinguished from
other types by their localization to pre-synaptic nerve
terminals, where they mediate calcium influx which con-
tributes to evoked neurotransmitter release and overall
synaptic function [2-4].
Inhibition of P/Q- and N-type channels resulting from
activation of G-protein coupled receptors (GPCRs)–a
crucial mode of regulation, notably illustrated in the
relief of pain sensations in response to opioid drugs [5]–
has been studied for over 25 years [6-16]. This mode of
regulation is complex and comprises multiple pathways
that include direct and indirect actions of G proteins on
the channel [17]. During membrane delimited G protein
inhibition, GPCR activation releases Gbg heterodimers
which then bind directly to the a1 subunits of P/Q- and
N-type channels, and this interaction stabilizes closed
channel conformations and culminates in channel inhi-
bition [18,19].
A recent study suggests that interaction of Gbg with
N-type channels can slow the kinetics of channel transi-
tion to inactivated states [20]. However, most studies of
the direct Gbg-presynaptic channel interaction have
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investigated the slowing of transition to activated chan-
nel states, and have found this mode of inhibition to be
more favored at hyperpolarized potentials, thus allowing
for activity dependent dis-inhibition [21-24]. Hence, the
term “voltage-dependent inhibition” (VDI) has been
used to describe two experimental hallmarks of this
Gbg-mediated regulation: slowing of presynaptic channel
activation, and relief of channel inhibition by a strong,
depolarizing pre-pulse.
Gbg-mediated VDI depends on a complex set of struc-
tural determinants that contribute to direct interaction
between Gbg and the presynaptic calcium channel. As
such, the extent of VDI varies with the isoforms of the
channel subunits and the G protein subunits in question
[17]. Structure-activity relationship studies of the inter-
action have revealed roles for three cytosolic regions of
the a1 subunit: the N-terminus, the I-II linker domain,
and the C-terminus [25-30]. While the C-terminal
region of the channel is thought to play a supporting
role as an enhancer of overall Gbg-channel binding affi-
nity [31], both the N-terminus and the I-II linker contri-
bute directly to the inhibitory interaction with Gbg.
Furthermore, contact between the N-terminus and the
I-II linker is demonstrated to be necessary for Gbg-
mediated VDI [25]. Efforts to resolve functionally
important Gbg-channel binding interactions have also
revealed the direct involvement of two nearby sections
of the I-II linker: amino acid residues 372-389 and 410-
428 [27,30]. The first of these sections partially overlaps
with the a1 subunit alpha interaction domain (AID) and
contains residues known to bind the calcium channel b
subunit, presumably in a manner that precludes many
of them from interaction with Gbg [32]. However, the
contribution of the other I-II linker residues in ques-
tion–to direct Gbg-binding and hence to channel inhibi-
tion–has remained unclear.
Here we aimed to further resolve the molecular deter-
minants of Gbg-mediated channel inhibition by testing
the functional contribution of individual residues in the
two above-mentioned sections of the a1B I-II linker.
Using a combination of alanine/cysteine scanning muta-
genesis and whole-cell electrophysiological recordings
from tsA-201 cells, we identify two residues of the I-II
linker, Arg376 and Val416, as key determinants of Gbg-




Wild type (WT) rat calcium channel subunit cDNAs
encoding Cav2.2 (a1B), Cavb1b, Cavb2a, Cavb3, and Cavb4,
and a2-δ1 subunits were generously donated by Dr.Terry
Snutch (University of British Columbia, Vancouver, BC).
The construction of cDNAs encoding WT human Gb1
and Gg2 subunits have been described previously [33].
Cav2.2 a1B mutants
cDNAs encoding single-residue Cav2.2 a1B mutants
were constructed by overlap extension PCR [34], using
WT a1B as the DNA template and Pfu turbo DNA poly-
merase (Stratagene) according to manufacturer’s instruc-
tions. AarI and BsiWI restriction sites, found in the
native sequence at locations flanking the mutagenized I-
II loop-encoding sequence, were included in the 5’ ends
of the non-mutagenic flanking primers. After mutagen-
izing and overlap extension reactions, mutant a1B
cDNA fragments were digested with AarI and BsiWI,
and then sub-cloned into the (AarI-, BsiWI-digested)
a1B mammalian expression vector, pCMV30-14G.
Codons for 27 residues within amino acid sequence
regions 372-389 and 410-428 were individually substi-
tuted to alanine, and three naturally occurring alanine
codons were substituted to cysteine. These 30 mutations
included: F372A, L373A, K374A, L375A, R376A, R377A,
Q378A, Q379A, E382A, R383A, N386A, K410A, S411A,
P412A, L413A, D414A, A415C, V416A, L417A, K418A,
R419A, A420C, A421C, T422A, K423A, K424A, S425A,
R426A, N427A, and D428A. cDNAs encoding four addi-
tional point mutations, R376E, R376F, V416E, and
V416K, and a double alanine mutation, (both R376A
and V416A), were also constructed using overlap/exten-
sion PCR as described above.
Tissue Culture and Transient Transfection
Human embryonic kidney tsA-201 cells were grown and
transiently transfected using the calcium phosphate
method as described previously (32). Transfection solu-
tions for individual culture dishes contained a mixture
of cDNA expression vectors, with the following quanti-
ties of each cDNA expression construct used: calcium
channel a1B subunit, 6 μg; Cavb subunit (6 μg), Cava2-
δ1 subunit (6 μg), Gb1 subunit, 6 μg; Gg2 subunit, 6 μg;
and 1 μg of a pEGFP marker vector (Clontech). Positive
controls contained the WT a1B subunit in place of
mutant a1B, and negative controls consisted of the WT
a1B subunit in the absence of exogenous Gb1g2. 12 hr
post-transfection, cells were washed 1× with PBS pH
7.4, supplemented with fresh DMEM, and allowed to
recover for an additional 12 hr. To prevent overgrowth,
cells were subsequently transferred to a 29°C incubator
and maintained for 24-72 hr prior to voltage-clamp
recording.
Cav2.2 Voltage Clamp Recordings
Glass coverslips carrying cells expressing mutant or WT
Cav2.2 channels were transferred to a 3.5-cm culture
dish (Corning) containing external recording solution
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consisting of 20 mM BaCl2, 1 mM MgCl2, 10 mM
HEPES, 40 mM TEA-Cl, 10 mM glucose, and 65 mM
CsCl (pH 7.2 adjusted with TEA-OH). Micro-electrode
patch pipettes were pulled using a Sutter P-87 micro-
electrode puller or a DMZ Universal puller, and manu-
ally fire-polished using a Narishige MF-830 Micro Forge
to attain a typical resistance of 4-5 MÙ. Internal pipette
solution consisted of 108 mM CsMeSO4, 4 mM MgCl2,
9 mM EGTA, and 9 mM HEPES (pH 7.2 adjusted with
CsOH).
Whole cell patch clamp recordings were performed in
voltage-clamp mode using an Axopatch 200B amplifier
(Axon Instruments) linked to a personal computer with
pCLAMP version 9.0 or 9.2 software. Series resistance
was compensated by 85%, leak currents were negligible,
and the data were filtered at 1 kHz. Individual pEGFP-
expressing cells were held at -100 mV, and currents
were evoked by stepping to a test potential of +20 mV.
Only cells with current amplitudes greater than 50 pA
and less than 1.5 nA were used for analysis.
Voltage-dependent G protein inhibition was assessed
by application of a strong, depolarizing pre-pulse (PP) to
+150 mV for 50 ms, immediately prior to the test
potential–during alternating sweeps of an assay. Pre-
pulse relief of inhibition was quantified as the ratio of
peak current amplitudes observed in paired test pulses
performed with (I+PP) and without (I-PP) the prepulse (i.
e., I+PP/I-PP).
Data Analysis
All data were analyzed using Clampfit version 9.2 (Axon
Instruments) and fitted in Sigmaplot 2000 (SPSS Inc.).
Statistical analyses were carried out using SigmaStat
2.03 (SPSS Inc.). All sample means are reported +/-
SEM. Statistically significant differences between means
were assessed using student’s t-test, Mann-Whitney
rank sum test, or one-way ANOVA at 95% confidence
level as appropriate.
Results
Previously, two sections of the N-type channel I-II linker
region, a1B amino acid residues 372-389 and 410-428,
were identified as functionally important binding sites
for the Gbg heterodimer [27,30]. To test the contribu-
tion of individual residues of these sections to Gbg-
mediated channel inhibition, alanine/cysteine scanning
mutagensis was performed. Residues 372-389 include six
amino acid residues that are predicted, on the basis of
crystallographic data, to be unavailable for interaction
with Gbg, as their access is likely occluded by the cal-
cium channel b subunit [32]. The remaining residues in
this section, and in the second region (residues 410-428)
were individually substituted to alanine or cysteine. The
resulting mutant channels were coexpressed with
human Gb1g2, and their respective susceptibilities to
Gbg-mediated VDI were quantified using a pre-pulse
facilitation (PPF) paradigm (Figure 1).
WT channels displayed the hallmark characteristics of
Gbg-mediated channel inhibition (Figure 1A, left),
including kinetic slowing of activation and relief of inhi-
bition by a strong depolarizing pre-pulse (PPF ratio for
WT channel assays: 2.36 +/- 0.23). When examining
PPF ratios obtained with mutant and WT channels, two
of the 30 mutants examined, R376A and V416A, showed
a significant loss of Gbg-mediated inhibition when com-
pared to wild type channels (PPF ratios 1.64 +/- 0.18
and 1.44 +/- 0.01, respectively; *P = 0.028 and 0.001,
respectively; see Figure 1B). To test whether or not the
effect of these mutations on Gbg-mediated channel inhi-
bition were additive, a double Cav2.2 a1B mutant con-
taining both the R376A and V416A substitutions was
engineered. Co-expression of this double mutant with
exogenous Gb1g2, and subsequent electrophysiological
analysis using the PPF protocol, found the degree of
Gbg-mediated inhibition to be significantly less than
that of WT channels, but similar to that observed in the
presence of either one of the individual mutations alone
(PPF ratio: 1.71 +/- 0.15, *t-test, P = 0.023) (Figure 2A).
To further characterize the roles of Arg376 and Val416,
additional single mutant a1B subunits, containing
R376E, R376F, V416E, and V416K substitutions, were
engineered and co-expressed with exogenous Gb1g2.
Neither of the latter Val416 substitutions resulted in sig-
nificant changes in PPF ratio as compared to WT chan-
nels, Fig. 2A). However, the phenylalanine substitution
at Arg376 significantly increased the PPF ratio for chan-
nels coexpressed with Gb1g2 (mean values of 2.36 and
3.62 for WT and R376F, respectively, t-test p < 0.017,
Fig. 2A), suggesting that this amino acid substitution
actually increased Gbg-mediated channel inhibition.
These data thus further support the notion of residue
376 being an important determinant of VD G protein
modulation of N-type channels.
The enhancement of Gbg-mediated VDI by the R376F
mutation, and the proximity of this mutation to critical
sites of interaction between the a1B and b subunits of
the Cav2.2 channel, led us to ask whether the nature of
the Cavb subunit might affect this enhancement. To
examine this issue, we coexpressed the a2-δ subunit and
the R376F mutant with different isoforms of the Cavb
subunit in tsA-201 cells, and for each resulting popula-
tion of Cav2.2 channels, we tested the effect of coexpres-
sion of heterologous Gb1g2 on current densities and PPF
ratios. As shown in Fig. 2B, little VD modulation was
observed in the absence of exogenously coexpressed
Gb1g2 irrespective of the type of calcium channel b sub-
unit that was present. For channels containing either
Cavb2a or Cavb4, coexpression with Gb1g2 induced
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robust VD modulation of channel activity, whose magni-
tude was, however, smaller than that observed with
channels containing Cavb1. Strikingly, virtually no VD
modulation was evident in R376F channels containing
the Cavb3 subunit (i.e., there was no significant differ-
ence in PPF in the presence and the absence of G pro-
teins). These data are in striking contrast to our
previous findings showing that with WT Cav2.2, Gb1g2
most strongly inhibited channels containing Cavb2a, fol-
lowed by Cavb3, Cavb4 and Cavb1B [35]. Hence, a single
amino acid substitution in the Cav2.2 I-II linker drasti-
cally alters the Cavb subunit dependence of Gb1g2 inhi-
bition of the channel.
Discussion
In this manuscript we have narrowly focused on the
contribution of individual amino acids in the Cav2.2 I-II
linker region to voltage dependent G protein inhibition
of the channel. Among thirty amino acids in the I-II
linker of the Cav2.2 channel, we have identified two,
Arg376 and Val416, that serve as determinants of G-pro-
tein mediated VDI of Cav2.2 channels, suggesting a
highly localized interaction of Gb1g2 with the I-II loop.
The impact of single amino acid substitutions on G pro-
tein inhibition is reminiscent of our earlier findings
showing that phosphorylation of a single I-II linker resi-
due, Thr422, can disrupt modulation of Cav2.2 channels
by Gb1 [36,37].
Arg376 is particularly interesting because the R376F
mutation drastically altered the impact of Cavb subunit
coexpression on the degree of VDI: whereas Gb1-
mediated inhibition of WT channels is reported to be
strongest for channels containing Cavb2a, followed by
Cavb3, Cavb4 and Cavb1B, respectively [35], we report
here that Gb1-mediated regulation of R376F channels is
strongest for channels containing Cavb1B, followed by
Cavb2a, Cavb4, Cavb3, respectively, with no significant
voltage-dependent inhibition observed for the latter. At
Figure 1 A: Three sets of typical current traces from tsA-201 cells expressing WT or mutant rat Cav2.2 calcium channels and Gb1g2, as
described in METHODS. Each is a matched set of current traces from sequential test pulses, with the second test pulse preceded by a150-mV
depolarizing prepulse. (Vertical and horizontal scale bars represent 15 pA and 15 ms, respectively; in each set the trace with larger current values
is from the second test pulse.) Left: traces from a cell expressing the WT channel and Gb1g2. Center: traces from a cell coexpressing the Cav2.2-
R376A mutant channel and Gb1g2. Right: traces from a cell coexpressing the Cav2.2-V416A mutant channel and Gb1g2. B: Histogram summarizing
the results of paired-pulse facilitation (PPF) experiments performed with all Ala/Cys point mutants of Cav2.2; columns show mean PPF values
with SE bars for each condition. Respective positions of mutations in the Cav2.2 amino acid sequence are indicated by numbers beneath the
corresponding columns (see METHODS for full description of the mutations used). Of the 30 individual amino acid residues examined in the
Cav2.2 I-II linker region, Ala mutations at both Arg
376 and Val416 (*p < 0.05, t-test) result in a significant loss of Gbg-mediated channel inhibition,
as measured by the degree of pre-pulse relief following a depolarizing pre-pulse, when compared to WT control. Numbers in parentheses
indicate numbers of cells tested.
Tedford et al. Molecular Brain 2010, 3:6
http://www.molecularbrain.com/content/3/1/6
Page 4 of 7
Figure 2 A: Histogram summarizing the results of PPF experiments performed with Cav2.2 isoforms carrying mutations of a1B residues
Arg376 and Val416. Columns show mean PPF values with SE bars for each condition. Human Gb1g2 was co-expressed in tsA-201 cells with the
Cav2.2 isoforms for each condition presented except for the negative control ("-Gb1g2“). Respective mutations in the Cav2.2 amino acid sequence
are indicated beneath the corresponding columns (see METHODS for full description of the mutations used). Of the various conditions examined
only the mutations R376A, R376F, V416A, and the double mutation R376A, V416A resulted in a significant loss of Gbg-mediated channel
inhibition, as measured by the degree of pre-pulse relief following a depolarizing pre-pulse, when compared to WT control (*p < 0.05, t-test, **p
< 0.05 one-way ANOVA, Dunnett’s method, or Kruskal-Wallis one-way ANOVA on ranks). Numbers in parentheses indicate numbers of cells tested
for the respective condition. B: Histogram summarizing the results of PPF experiments using tsA-201 cells co-transfected to express a1B mutant
R376F with Cavb isoforms b1B, b2, b3, and b4, with or without heterologous human Gb1g2 as indicated by labels beneath columns. Columns show
mean PPF values with SE bars for each condition (see METHODS for full description of the mutations used). Of the conditions examined,
coexpression of Cavb1B and Cavb2a, and Cavb4 resulted in statistically significant differences in mean current density for R376F channels expressed
with and without heterologous Gbg (*p < 0.05 using t-test, Mann-Whitney rank sum test, and t-test, respectively).
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this point we do not know how the mutation of residue
376 to phenylalanine increases VD G protein inhibition.
When coexpressed with Cavb1B in the absence of het-
erologous Gb1g2, the R376F mutant had a half activation
potential that did not differ significantly from that of
the wild type channels (data not shown); moreover, at
the majority of test potentials examined, the mutation
yielded no significant changes in the rates of activation
and inactivation (versus WT channels, data not shown),
suggesting that the effects of the mutation on Gbg mod-
ulation are not complicated by changes in biophysical
properties of the channel. An increased degree of pre-
pulse relief could occur as a result of several mechan-
isms. First, the mutation could destabilize the binding of
Gbg to the channel, thus resulting in more effective dis-
sociation of Gbg from the channel in response to mem-
brane depolarization. This however seems unlikely,
because the kinetics of the facilitated current were
found to be similar for both the wild type and the
mutant channels, indicating that both channels are com-
pletely dis-inhibited (and thus dissociated from Gbg) fol-
lowing the application of a prepulse (data not shown).
Agler and colleagues [25] reported that the N-terminus
of Cav2.2 is capable of interacting with the domain I-II
linker, and that this interaction contributes to G protein
inhibition of the channel. It is thus conceivable that the
nature of residue 376 could affect G protein inhibition
indirectly by virtue of altering the binding of the N-ter-
minus to the I-II linker.
Alternatively, it is possible that residue 376 is involved
in transducing Gbg binding to alter channel gating, such
that a stronger voltage dependent inhibition is observed
in the mutant channel. Residue 376 is three amino acid
residues just upstream of an alpha helical structure (the
AID, comprising residues 379-396) that is involved in
binding of the Cavb subunit [38], and could potentially
serve as a hinge that links G protein binding to the gat-
ing machinery of the channel. However, it has also been
proposed for Cav2.1 channels that I-II linker residues
357-378 are all part of a stable continuation of the alpha
helical structure of the AID, and that stability and conti-
nuity of this helical structure is required for VD G pro-
tein inhibition of the channel [39]. In the latter case the
R376F mutation may simply create a more stable bind-
ing pocket for Gbg, perhaps in part by eliminating one
of the eight positive charges carried by the side chains
of I-II residues 357-396, which may render this section
of the I-II linker less likely to move in response to a
membrane depolarization event. Whatever the actual
case, the proximity of Arg376 to the Cavb subunit inter-
action site also provides for a mechanism by which the
nature of the Cavb subunit could affect the extent of G
protein inhibition that is observed.
Although alanine mutagenesis of residues 376 and 416
significantly reduced the effects of Gbg, VDI was not
completely eliminated, and the effects of the individual
amino acid substitutions were not additive. This sug-
gests that either other amino acid residues in the Cav2.2
a1 subunit might help stabilize the binding of Gbg to
the channel (such as for example, residue in the N-ter-
minus), or that the Cavb subunit may contribute directly
to anchoring Gbg to the channel. The latter would be
consistent with recent findings showing that the pre-
sence of the Cavb subunit is required to permit VDI of
Cav2.1 channels [39].
Altogether, our data further implicate the domain I-II
linker region as an important contributor to voltage
dependent G protein modulation of N-type calcium
channels. Furthermore, our results suggest that the reg-
ulation of N-type calcium channels by G proteins
involves complex interactions between Gbg, the Cav2.2
a1 subunit, and the auxiliary Cavb subunit, and reveal
that substitution of a single amino acid residue that is
conserved in all HVA calcium channels is sufficient to
significantly alter the interactions among these players.
Although the precise molecular mechanism by which
residue 376 couples Gbg interactions to alterations in
channel function remains unknown, the observation that
highly localized alteration of a single amino acid residue
increased G protein inhibition of the channel may offer
potential avenues to enhance the efficacy of therapeutics
acting on N-type channels via GPCRs.
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